Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

de cancer.

Durere severă, invalidantă, indusă de cancer, care nu

răspunde la analgezice non-opioide.

Durere cronică severă, invalidantă, care nu răspunde la

analgezice non-opioide, unde durata totală a

tratamentului opioid este mai scurtă de 12 luni.

Risc înalt de apariţie a dependenţei.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare acestui DCI.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N02AA05 OXYCODONUM COMPR. FILM. ELIB. 10 mg

MODIF.

OXYCONTIN(R) 10 mg 10 mg MUNDIPHARMA GMBH

N02AA05 OXYCODONUM COMPR. FILM. ELIB. 20 mg

MODIF.

OXYCONTIN(R) 20 mg 20 mg MUNDIPHARMA GMBH
N02AA05 OXYCODONUM COMPR. FILM. ELIB. 40 mg

MODIF.

OXYCONTIN(R) 40 mg 40 mg MUNDIPHARMA GMBH
N02AA05 OXYCODONUM COMPR. FILM. ELIB. 80 mg

MODIF.

OXYCONTIN(R) 80 mg 80 mg MUNDIPHARMA GMBH

________________________________________________________________________________

______________________________________________________________________________

| 439 |N02AA08| DIHYDROCODEINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL. 120 mg

DHC CONTINUS 120 mg 120 mg MUNDIPHARMA GMBH
N02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL. 60 mg

DHC CONTINUS 60 mg 60 mg MUNDIPHARMA GMBH

N02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL. 90 mg

DHC CONTINUS 90 mg 90 mg MUNDIPHARMA GMBH

________________________________________________________________________________
______________________________________________________________________________

| 440 |N02AB02| PETHIDINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N02AB02 PETHIDINUM SOL. INJ. 50 mg/ml

MIALGIN(R) 100 mg/2 ml 50 mg/ml ZENTIVA SA

________________________________________________________________________________

______________________________________________________________________________

| 441 |N02AB03| FENTANYLUM** | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Durere severă, invalidantă, asociată cu diagnosticul